Strategic Global Advisors, LLC Taro Pharmaceutical Industries LTD Transaction History

Strategic Global Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$75.36 - $86.57 $5.53 Million - $6.36 Million	-73,431 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$83.92 - $108.88 $94,242 - $122,272	1,123 Added 1.55%	73,431 $6.27 Million
Q1 2019 May 13, 2019	BUY	$85.97 - $108.09 $26,478 - $33,291	308 Added 0.43%	72,308 $7.82 Million
Q4 2018 Feb 13, 2019	SELL	$78.25 - $107.92 $148,518 - $204,832	-1,898 Reduced 2.57%	72,000 $6.09 Million
Q3 2018 Nov 14, 2018	SELL	$97.82 - $116.09 $17,607 - $20,896	-180 Reduced 0.24%	73,898 $7.26 Million

Q4 2017 Feb 14, 2018	SELL	$104.5 - $126.38 $77,434 - $93,647	-741 Reduced 0.99%	74,078 $7.76 Million
Q3 2017 Nov 13, 2017	BUY	$97.26 - $116.2 $7.28 Million - $8.69 Million	74,819	74,819 $8.43 Million

4.64M

6.3K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Strategic Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Global Advisors, LLC with notifications on news.